Cytotoxic cardiac glycosides and other compounds from Asclepias syriaca

J Nat Prod. 2012 Mar 23;75(3):400-7. doi: 10.1021/np2008076. Epub 2012 Feb 8.

Abstract

Phytochemical investigation of the dried biomass of Asclepias syriaca afforded five new compounds (1-5), along with 19 known structures. Overall, the secondary metabolites isolated and identified from this plant showed a wide structural diversity including pentacyclic triterpenes, cardiac glycosides, flavonoid glycosides, lignans, a phenylethanoid, and a glycosylated megastigmane. In addition, the isolates were tested against the cancer breast cell line Hs578T, and those showing IC(50) values lower than 50 μM (1 and 6-9) were further investigated in three additional breast cancer cell lines (MCF-7, T47D, and Sk-Br-3) and the normal breast cell line Hs578Bst.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / isolation & purification*
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Asclepias / chemistry*
  • Cardiac Glycosides / chemistry
  • Cardiac Glycosides / isolation & purification*
  • Cardiac Glycosides / pharmacology*
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • Inhibitory Concentration 50
  • Molecular Structure
  • Nuclear Magnetic Resonance, Biomolecular
  • Triterpenes / chemistry

Substances

  • Antineoplastic Agents, Phytogenic
  • Cardiac Glycosides
  • Triterpenes